Our commitment as a Public Benefit Corporation

We believe everyone should have access to their genome.

Your genome is one of the most fundamental and personal sources of information about you. It should be something you can download, keep, explore without giving up your privacy or rights.

That is why we built Genome Computer.

Genomic data is different from ordinary user data. It is persistent. It is identifying. It can reveal information about you and, often, people related to you. Once it exists as a digital file, it can be copied, analyzed and reused indefinitely.

We do not believe data this sensitive should ever become a company’s secondary business model.

That is why The Genome Computer Company is operated by Genetic Superintelligence Company, a Delaware Public Benefit Corporation.

Privacy should not depend on good intentions

Companies change.

Leadership changes. Investors change. Markets change. Companies get acquired. Business models evolve.

A privacy policy can change too.

That is why we do not think protecting genomic data can depend solely on a promise that a company makes today. The structure of the company should reinforce the promise, particularly when there is pressure to do something more profitable with the data later.

Our Public Benefit Corporation exists in part to do exactly that.

What our Public Benefit Corporation means

A Public Benefit Corporation is a for-profit company, but its directors are required to consider more than shareholder value alone. They must also consider the company’s stated public benefit and the interests of people materially affected by its conduct.

For us, that public benefit includes advancing human understanding while keeping identifiable individual genomic data under individual control and off the market.

In plain terms:

We do not sell or license your individual genetic data.

That commitment matters precisely because genomic datasets can be commercially valuable.

We are not building a genomic database to sell later. We are not creating a research-consent funnel. We are not asking you to contribute your DNA so somebody else can monetize it.

You are paying us to sequence your genome, annotate it, and give it to you.

Your genome is the product

Genome Computer is designed around a simple idea: you, and you only, should have access to your genome.

We sequence your sample, annotate it, and deliver it in a format designed to be useful with modern software and AI.

A .genome bundle can be searched by tools like Codex or Claude Code, compared against new scientific literature, used to build personal software, and reinterpreted as genomic knowledge improves.

The value is what the genome enables for you.

There is no second transaction in which your genomic data becomes the product for somebody else.

Our privacy commitments reflect that. We do not sell your genetic data. We do not license identifiable genomic data. We do not use identifiable genomic data to train AI models. We do not commercially distribute de-identified or aggregated genomic datasets.

And we do not share your data with researchers, pharmaceutical companies, insurers or other third parties except where required to provide the service or compelled by valid legal process.

Why this matters more with AI

AI makes genomic data dramatically more useful.

A traditional genetic report gives you a fixed set of interpretations chosen by the company that produced it. A .genome file is different. It can be searched, queried and reinterpreted as science and software improve.

That is the point.

Your genome should not be trapped inside a dashboard. It should be something your tools can work with.

But open-ended usefulness requires trust.

If we are going to help people bring their genomes into Codex, Claude Code and whatever personal AI systems come next, they should not also have to wonder whether Genome Computer is quietly building another business from the same data.

The PBC structure is one part of how we make that commitment durable.

It does not replace encryption, deletion, access controls, carefully selected laboratory partners or operational security. It reinforces the principle underneath all of them:

Your genome belongs to you.

Built around that principle

Our systems and relationships with laboratory partners are designed around minimizing the amount of identifying information attached to genomic samples and limiting how long samples and genomic deliverables are retained.

Samples sent to our laboratory partners are de-identified. Our laboratory partners are contractually prohibited from selling, licensing or commercially distributing data derived from customer samples. Samples and sequencing deliverables are subject to defined retention periods rather than being stored indefinitely.

When you receive your genome, it is yours to download and keep.

That is a very different model from building a permanent genomic database whose value grows with every additional customer.

We think that distinction matters.

The company has to match the material

We believe everyone should have access to their genome.

But people will only feel comfortable doing that if they can trust the organizations handling it.

For something this personal, we do not think an ordinary privacy promise is enough. The product architecture, commercial model and corporate structure should all point in the same direction.

That is why Genome Computer is operated by a Public Benefit Corporation.

Your genome should be useful. And it should remain yours.

Read the Genome Computer Privacy Policy and Terms of Service.